Advanced Enzyme IPO Details

Issue Open Jul 20, 2016
Issue Close Jul 22, 2016
IPO Price ₹896
Face Value ₹10
IPO Size ₹411.49 Cr
Listing At BSE, NSE
IPO Lot Size 16
  1. MPM-backed Were­wolf, Mer­ck-part­nered Arti­va make quick IPO flip while Lu­ca Santarel­lis biotech rais­es $127.5M

    Fri, 09 Apr 2021 03:28:00 GMT

    The jump from crossover rounds to biotech IPO is quick­er than ever ... monotherapy portion of a Phase I/IIa study in patients with advanced solid tumors, according to data presented Saturday ...

  2. Instil Bio’s upsized IPO raises $320M for clinical tests of TIL cancer cell therapy

    Fri, 19 Mar 2021 08:22:00 GMT

    Instil is chasing Iovance Biotherapeutics, which has advanced ... of an enzyme called GLB. In its prospectus, Gain said it would use between $7 million and $9 million of the IPO proceeds to ...

  3. Precision Bio’s IPO Raises $126M for Pipeline of Gene-Edited Drugs

    Fri, 26 Mar 2021 17:00:00 GMT

    The company says in its IPO prospectus that ARCUS reprograms a gene-editing enzyme called I-Crel ... Precision Bio’s most advanced therapeutic candidate, PBCAR0191, is an allogeneic cell ...

  4. Protein misfolding specialist Gain nets $40m from IPO

    Fri, 19 Mar 2021 02:45:00 GMT

    The company has developed a toolkit called Site-Directed Enzyme Enhancement Therapy or SEE ... Around $7 to $9 million from the proceeds of the IPO will be used to advance Gain’s preclinical ...

  5. Design Therapeutics leads way as 4 bio IPOs raise $641M for clinical research

    Fri, 26 Mar 2021 12:42:00 GMT

    Momentum in biotech IPOs continued this week as four more companies ... is set aside for developing a drug that blocks ERK5, an enzyme in the RAS signaling pathway. The cash is expected to support ...

  6. Turning Point Therapeutics Plans IPO to Advance Targeted Cancer Drugs

    Sun, 21 Mar 2021 16:59:00 GMT

    Turning Point Therapeutics, which is developing targeted cancer drugs for patients whose tumors resist other precision therapies, has outlined plans for an IPO. The company, which started ...

  7. Investing in CRISPR Stocks: Ultimate Genetic Editing Guide

    Wed, 31 Mar 2021 13:55:00 GMT

    We’ll be covering investment opportunities ranging from genetic editing (see below) to electric vehicles to SPAC IPOs and much more ... It promptly deploys a Cas9 enzyme to “cut” the ...

  8. Vizio stock sputters in trading debut as IPO market appears to cool

    Thu, 25 Mar 2021 10:28:00 GMT

    Vizio Holding Corp. shares opened below their initial-public-offering price Thursday afternoon in a sign that the once-hot IPO market could be cooling. Shares of the company, which makes smart ...

  9. Biodesix Announces Fourth Quarter and Full Year 2020 Results

    Tue, 16 Mar 2021 12:03:00 GMT

    Successful initial public offering (IPO) raising net proceeds of $63.8 ... support treatment decisions for patients diagnosed with advanced non-small cell lung cancer (NSCLC).

Advanced Enzyme IPO Alerts

1. Advanced Enzyme Technologies Ltd IPO - Listing  Friday, July 29, 2016 7:05:19 AM

Advanced Enzyme IPO Listing Date & Information:

› Listing Date: Monday, August 1, 2016
› BSE Script Code: 540025
› NSE Symbol: ADVENZYMES
› Listing In: B Group of Securities
› ISIN: INE837H01012
› Issue Price: Rs. 896.00 Per Equity Share
› Face Value: Rs. 10.00 Per Equity Share

2. Advanced Enzyme Technologies Ltd IPO - Allotment  Thursday, July 28, 2016 7:03:45 AM

Advanced Enzyme Technologies Ltd IPO Allotment Status is now available online.

Advanced Enzyme Technologies Ltd is an India based company engaged in research, development, manufacturing and marketing of Healthcare, Nutrition and Bio-Processing products.

The Initial Public Offer of Advanced Enzyme subscribed 116.02 times (11.67 times in retail). Public Issue of Advanced Enzyme was closed for subscription on Jul 22, 2016.

3. Final Subscription Detail - Advanced Enzyme IPO  Friday, July 22, 2016 3:08:26 PM

Advanced Enzyme Technologies IPO Final Subscription Detail (BSE+NSE):

 

ADVANCED ENZYME TECHNOLOGIES LIMITED
Sr.No. Category No.of shares offered/reserved No. of shares bid for No. of times of total meant for the category
1 Qualified Institutional Buyers (QIBs) 918908 86406528 94.03
1(a) Foreign Institutional Investors(FIIs)      
1(b) Domestic Financial Institutions(Banks/ Financial Institutions(FIs)/ Insurance Companies)      
1(c) Mutual funds      
1(d) Others      
2 Non Institutional Investors 686989 270055920 393.10
2(a) Corporates      
2(b) Individuals(Other than RIIs)      
2(c) Others      
3 Retail Individual Investors(RIIs) 1602974 18699488 11.67
3(a) Cut Off      
3(b) Price bids      
4 Employees 25188 43584 1.73
3(a) Cut Off      
3(b) Price bids      
  Total 3234059 375205520 116.02
Updated as on 22 July 2016 at 2300 hrs

4. Advanced Enzyme Technologies Ltd IPO - Close  Friday, July 15, 2016 10:16:05 AM

Advanced Enzyme Technologies Ltd IPO to open on Jul 20, 2016 and close for subscription on Jul 22, 2016. Company is coming with IPO to sell 4,034,470 equity shares by the promoter of the company and raising Rs 50.00 Cr through a fresh issue. The equity shares of the company to be list at BSE and NSE.

5. Advanced Enzyme Technologies Ltd IPO - Open  Friday, July 15, 2016 10:15:48 AM

Advanced Enzyme Technologies Ltd is entering in the capital markets with an initial public offering (IPO) to carry out the sale of up to 4,034,470 equity shares by the selling shareholder. In addition, company is raise Rs 50.00 Cr through a fresh issue to invest in Advanced Enzymes USA, the wholly owned subsidiary for repayment / pre-payment of certain loans availed by Advanced Enzymes USA. The price band for the issue has been fixed at Rs 880 at lower level and Rs 896 at upper level.

Incorporated in 1989, Advanced Enzyme Technologies Ltd is an India based company engaged in research, development, manufacturing and marketing of Healthcare, Nutrition and Bio-Processing products.

The issue opens on Jul 20, 2016 and closes for subscription on Jul 22, 2016. The equity shares of the issue are proposed to be list on the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE).

Advanced Enzyme IPO News & Events FAQs

  1. 1. When Advanced Enzyme IPO expected date?

    The Advanced Enzyme IPO is proposed to open on Jul 20, 2016. The IPO application ends on Jul 22, 2016.

  2. 2. How to purchase Advanced Enzyme IPO?

    Retail investors can apply in the retail or non-institutional investor category from Jul 20, 2016 to Jul 22, 2016. The Advanced Enzyme IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).

  3. 3. When Advanced Enzyme IPO will come?

    The Advanced Enzyme IPO will open for subscription on Jul 20, 2016. The public issue will close on Jul 22, 2016.


Comments

   I Like It. | Report Abuse








Search Chittorgarh.com:

Download Our Mobile App

Android App iOS App